Samples from a large UK screening trial supported validation of the investigational Evident ovarian cancer test, according to Dawn Mattoon, PhD.
|Videos|January 8, 2021
Cervical Cancer Screening: Protecting and Improving Health Outcomes of Women
Expert provides insights regarding current cervical cancer screening guidelines, in addition to the role obstetricians and gynecologists play in protecting women’s health.
Advertisement
Supported by: Hologic
Jessica Shepherd, MD, MBA
Baylor University Medical Center
Dallas, Texas
To view the publication associated with this Contemporary OB/GYN® Clinical Consult, click
Advertisement
Related to this article
Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Distress, not low libido alone, defines HSDD, which requires a biopsychosocial evaluation, according to Holly N. Thomas, MD, MS.
Open-ended questions help ob-gyns untangle GSM and low desire and build adherence-focused treatment plans, according to Sheryl Kingsberg, PhD.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule
2
FAQ: Who is a candidate for testosterone therapy in women?
3
FAQ: What does the evidence show about testosterone in women?
4
Q&A: Kanchi Chadha, MD, FACOG, MSCP, on FDA boxed warning removals
5